Meg Dodge

Meg Dodge currently serves as the Vice President of Investor Relations and Corporate Communications at Rocket Pharmaceuticals since April 2024 and has been the Head of Investor Relations and Corporate Communication at Krystal Biotech, Inc. since April 2022. Prior experience includes roles in Corporate Development and Strategy, as well as Investor Relations at Équilibre BioPharmaceuticals Corp. from June 2019 to April 2022, and Executive Director at Morgan Stanley from April 2018 to May 2019. Additionally, Meg Dodge held the position of Senior Vice President at Goldman Sachs from July 2011 to April 2018. Meg Dodge holds a Master of Laws (LLM) from New York University School of Law, a JD from Syracuse University College of Law, a Bachelor of Arts (BA) from Colby College, and a high school diploma from Kent School.